You should reach out if you experience severe weakness, dizziness that does not improve, fainting, ongoing vomiting, difficulty staying hydrated, severe abdominal pain, signs of low blood sugar, or symptoms that interfere with normal daily activities
Those additions raise the risk of allergic or adverse reactions
Treatment with semaglutide resulted in a statistically significant reduction in HbA 1c after 30 weeks of treatment compared to placebo (see Table 7)
hence, treatment guidelines do not recommend these agents in pregnancy. Thus, the lack of data on the safety of second-line noninsulin antidiabetic medications in the prenatal period has been a barrier to their use in pregnant women even when they may be beneficial, particularly for patients that dont need or dont tolerate insulin injections, Dr
, , , , L- ,
The article names hypertension, dyslipidemia, sleep apnea and PCOS as conditions that strengthen the case